Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
362
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
+389K
-
Total reported value, excl. options
-
$6.22B
-
Value change
-
+$101M
-
Put/Call ratio
-
0.36
-
Number of buys
-
165
-
Number of sells
-
-156
-
Price
-
$134.54
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2018
398 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2018.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 362 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
of 50.5M outstanding shares and own 91.64% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (5.21M shares), BlackRock Inc. (4.51M shares), FMR LLC (1.87M shares), RENAISSANCE TECHNOLOGIES LLC (1.72M shares), AQR CAPITAL MANAGEMENT LLC (1.62M shares), FIL Ltd (1.43M shares), WELLS FARGO & COMPANY/MN (1.39M shares), ARIEL INVESTMENTS, LLC (1.25M shares), STATE STREET CORP (1.21M shares), and TimesSquare Capital Management, LLC (1.16M shares).
This table shows the top 362 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.